A comprehensive view of Epidemic/Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Kaiser Health News reports government-funded courses of Pfizer’s Paxlovid antiviral expected to run out in a few months, cutting access to the treatment to the uninsured and seniors; about 6 million people have take Paxlovid in US

Commentary: 60% of China might get COVID in initial surge of cases as nation loosens policies, and 90% could be infected when disease makes its way through population, expert warns; one model predicts 20,000 COVID deaths/day at current pace of reopening

Commentary: China's shift from tough COVID policies could depress growth in next few months as infections rise, economists say; Hwabao Trust cuts Q1 growth forecast to 3.5%-4% from 5%, citing risk of outbreaks during Lunar New Year celebrations in January

Moderna receives FDA emergency use authorization for Omicron-targeting bivalent COVID-19 booster vaccine in children six months through five years of age

Pfizer and BioNTech get FDA emergency use authorization for Omicron-adapted bivalent COVID-19 vaccine in children under 5 years; many states report over 90% of pediatric beds are occupied due to COVID-19 cases, rise in seasonal respiratory illnesses

Ask us about our Pulp & Paper Industry market view

Trending Chart

Interactive chart with headline count